Merck 1Q net quadruples as cancer drug, vaccine sales soar
“… [Merck] posted higher sales for all its vaccines, particularly Gardasil… Sales of key childhood vaccines, including one that prevents measles, jumped 27% to a total of $496 million. Merck is the only U.S. supplier of the measles-mumps-rubella vaccine and has increased production amid the country’s worst outbreak since measles was declared eradicated here in 2000.”
Global vaccine market revenues from 2014 to 2020 (inbillion U.S. dollars)
“The global vaccine market is showing some escalating growth and it is expected that it will reach total revenues of nearly 60 billion U.S. dollars by 2020. That would be almost double the size the market had back in 2014.”
“Paediatric segment accounted for more than 50% market share in 2018 and is forecast to witness substantial growth over the forecast years. Improved level of vaccine recommendation by
CDC for monotonous immunization for children below 6 years will fuel the business growth…”
“U.S. accounted for more than 35% market share of global market in 2018. Growing initiatives by HHS to reduce infectious diseases by increasing immunization rates and immunization
recommendations will fuel U.S. market growth. For instance, the Healthy People 2020 aims for immunization to prevent and treat infectious diseases.”
https://www.gminsights.com/industry-analysis/vaccines-market
